Treatment of Kawasaki disease with a moderate dose (1 g/kg) of intravenous immunoglobulin

Journal of the Medical Association of Thailand

Volumn 85, Issue SUPPL. 4, 2002, Pages

  Khowsathit, Pongsak ^a   Hong Hgam, Chutima ^a   Khositseth, Anant ^a   Wanitkun, Suthep ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Coronary Abnormality; Intravenous Immunoglobulin; IVIG; Kawasaki Disease

Indexed keywords

ACETYLSALICYLIC ACID; IMMUNOGLOBULIN;

ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CONVALESCENCE; CORONARY ARTERY DISEASE; DISEASE COURSE; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRESCHOOL CHILD; RETROSPECTIVE STUDY; TREATMENT FAILURE;

CHILD, PRESCHOOL; CORONARY ARTERIOSCLEROSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFANT; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; RETROSPECTIVE STUDIES;

EID: 0036880939     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Furusho K, Kamiya T, Nakano H, et al. Intravenous gamma-globulin for Kawasaki disease. Acta Paediatr Jpn 1991; 33: 799-804.
2. Newburger JW, Takahashi M, Beiser AS, et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med 1991; 324: 1633-9.
3. Newburger JW. Treatment of Kawasaki disease. Lancet 1996; 347: 1128.
4. Burns JC, Capparelli EV, Brown JA, Newburger JW, Glode MP. Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. US/ Canadian Kawasaki Syndrome Study Group. Pediatr Infect Dis J 1998; 17: 1144-8.
5. Barron KS, Murphy DJ Jr, Silverman ED, et al. Treatment of Kawasaki syndrome: A comparison of two dosage regimens of intravenously administered immune globulin. J Pediatr 1990; 117: 638-44.
6. Harada K. Intravenous gamma-globulin treatment in Kawasaki disease. Acta Paediatr Jpn 1991; 33: 805-10.
7. Morikawa Y, Ohashi Y, Harada K, et al. A multicenter, randomized, controlled trial of intravenous gamma globulin therapy in children with acute Kawasaki disease. Acta Paediatr Jpn 1994; 36: 347-54.
8. Sato N, Sugimura T, Akagi T, et al. Selective high dose gamma-globulin treatment in Kawasaki disease: Assessment of clinical aspects and cost effectiveness. Pediatr Int 1999; 41: 1-7.
9. Durongpisitkul K, Gururaj VJ, Park JM, Martin CF. The prevention of coronary artery aneurysm in Kawasaki disease: A meta-analysis on the efficacy of aspirin and immunoglobulin treatment. Pediatrics 1995;96: 1057-61.
10. Engle MA, Fatica NS, Bussel JB, O'Loughlin JE, Snyder MS, Lesser ML. Clinical trial of single-dose intravenous gamma globulin in acute Kawasaki disease. Preliminary report. Am J Dis Child 1989; 143: 1300-4.
11. Dajani AS, Taubert KA, Gerber MA, et al. Diagnosis and therapy of Kawasaki disease in children. Circulation 1993; 87: 1776-80.
12. Arjunan K, Daniels SR, Meyer RA, et al. Coronary artery caliber in normal children and patients with Kawasaki disease but without aneurysms: An echocardiographic and angiographic study. J Am Coll Cardiol 1986; 8: 1119-24.
13. Furusho K, Kamiya T, Nakano H, et al. High dose intravenous gammaglobulin for Kawasaki disease. Lancet 1984; 2: 1055-8.
14. Morikawa Y, Ohashi Y, Harada K, et al. A multicenter randomized controlled trial of intravenous gamma globulin therapy in children with acute Kawasaki disease. Acta Paediatr Jpn 1994; 36: 347-54.
15. Terai M, Shulman S. Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose. J Pediatr 1997; 131: 888-93.
16. Yanakawa H, Nakamura Y, Sakata K, Yashiro M. Use of intravenous gamma globulin for Kawasaki disease: Effects on cardiac sequelae. Pediatr Cardiol 1997; 18: 19-23.
17. Han RK, Silverman ED, Newman A, McCrindle BW. Management and outcome of persistent or recurrent therapy in acute Kawasaki disease. Arch Pediatr Adolesc Med 2000; 154: 694-9.